The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Prize winner 2019

Olov Andersson. Picture.
Olov Andersson

Prize winner

Olov Andersson
Dept of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden

Olov Andersson’s research addresses one of the most important aspects of diabetes: how can we find new targets for effective and safe treatment of these diseases. One major approach Andersson has pursued is stimulation of the generation/regeneration of islet cells, thereby improving insulin secretion. Here, his work has been innovative and ground-breaking, in that he is employing zebrafish. These organisms are versatile and exhibit many physiological features that can be used to monitor and assess bodily functions relevant to diabetes.
Thus, extensive screens of chemical compounds that could be used to target mechanisms involved in diabetes pathophysiology can be undertaken in zebrafish.                                                                                                                                                                                                  

20 Dec 2021